1. Sovaldi and Harvoni can now be used to treat hepatitis C virus in patients ages 12 to 17.
2. 23andMe’s at-home DNA tests allow consumers to assess their genetic risks for 10 different diseases.
3. Austedo is intended to treat chorea — an involuntary movement disorder associated with Huntington’s disease.
4. Ingrezza is the first FDA-approved treatment for tardive dyskinesia, or uncontrolled movements of the face and body.
More articles on supply chain:
FDA: St. Jude Medical downplayed device defect and delayed recall for years
Why this pork producer has its eye on the transplant market
Supply chain tip of the week: Hospital linens cost more than you think
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.